Tirzepatide vs Semaglutide: What UK Patients Should Know About GLP-1 Treatments in 2026
Two medications are transforming how UK clinicians manage type 2 diabetes and obesity: Semaglutide and Tirzepatide. Both belong to a […]
Two medications are transforming how UK clinicians manage type 2 diabetes and obesity: Semaglutide and Tirzepatide. Both belong to a […]
By Daniel Obahor, GPhC-registered pharmacist and founder of CardivaRx Ltd. This article draws on UK formulary analysis, OpenPrescribing data, NICE
Introduction Many UK adults don’t know their cholesterol numbers, and even fewer understand what those numbers actually mean for their
Wondering how the NHS free blood pressure check vs private hypertension treatment options compare for UK adults in 2026? This
Introduction Private treatment for type 2 diabetes in the UK has changed dramatically in 2026. The NICE NG28 guideline, the
Introduction Private hypertension treatment in the UK has quietly become one of the fastest-growing areas of self-pay healthcare. NHS GP
Introduction A pharmacist independent prescriber in the UK is a qualified healthcare professional who can assess, diagnose, and prescribe medicines